NPK International clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NPK International Inc.
NPKI · the NYSE · USD · Market cap $914M · 510 employees
NPK International Inc., a temporary worksite access solutions company, manufactures, sells, and rents recyclable composite matting products in the United States and United Kingdom.
Not yet scoredPrice as of 5 Nov 2026Daily close, not a live quote
Screened 2026-11-05 · the tape above runs as of 02:02 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price8.62 USD at the 5 Nov 2026 close
- Fair valueUnder review: our model's value is 1.53x the price, above our 1.35x limit.
- Our regime readDistribution, as of 7 Nov 2026
- Ethical screenNot yet scored
- Last reviewed5 Nov 2026 (2 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: range not available (screen dated 2026-11-05).
- Trend Distribution
- Insiders insiders bought, latest filing 2026-11-02
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical screen not yet scored
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
NPK International Inc. holds its Distribution at $8.62. The statistical read favours the sellers, held for 1 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the sellers, held for 1 days |
| Price at the screen | $8.62 |
| Valuation | 23.39 trailing · 17.17 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 1.47 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 6.05% | Below 33% | Interest-bearing debt is just 6.1% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 13.12% | Below 49% | Money owed to the company is 13.1% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
NPK International clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
NPK International clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 6%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value under review. Our model's value is 1.53x the price, above our 1.35x limit. We show no fair value, margin of safety or value read built on it until the review clears.
How a fair value is estimated: discounted cash flow (DCF).
The Street's RangeThird-party analyst targets. The average target sits +144% from the screen price.
Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsEnergy Matting Rentals Hit a Cyclical Ceiling
Picture a contractor laying temporary floors only when the oil rigs are running flat out. NPKI sells and rents those floors, yet the shares already trade above our fair value with a negative margin of safety and a forward multiple of 23 times. Revenue growth of 16 percent and a 14 percent profit margin look respectable on paper, but they sit inside an industry that expands and contracts with energy spending rather than any durable advantage.
We therefore pass. The business clears our ethical screen without issue, yet the combination of unknown moat, modest 10 percent return on equity and a price well clear of intrinsic value leaves no margin for error. Three analysts may eye a higher target, but that does not change the arithmetic.
The real risk is the classic cyclical trap. Earnings can look strong near the top of an energy cycle, making any multiple appear reasonable until the next downturn arrives and peak profits disappear. Analysis, not advice.
| Forward P/E | 17.2xfairly priced for its growth rate |
| Trailing P/E | 23.4xa premium valuation |
| EPS, trailing | 0.46 |
| EPS, forward | 0.63 |
| Revenue growth | +19.6%steady growth |
| Profit margin | 14.2%thin but positive margins |
| Return on equity | 11.2%a modest return on shareholder capital |
| FCF yield | 1.95% |
| Debt to equity | 0.05minimal debt: a conservative balance sheet |
| Current ratio | 1.61healthy short-term liquidity |
| Beta | 1.47moves a little more than the market |
| Short interest, float | 0.03% |
| 52-week range | 10.55 - 16.50 |
| Market cap | $914M |
| Employees | 510 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeNPKI trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 17.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading bearish. Over the past year the shares are up 76%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it none, with a mean price target of $20. Insiders have been net buyers over the past quarter.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.2% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bearish. Over the past year the shares are up 76%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it none, with a mean price target of $20. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bearish. Over the past year the shares are up 76%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it none, with a mean price target of $20. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bearish. Over the past year the shares are up 76%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it none, with a mean price target of $20. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bearish. Over the past year the shares are up 76%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it none, with a mean price target of $20. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bearish. Over the past year the shares are up 76%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it none, with a mean price target of $20. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bearish. Over the past year the shares are up 76%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it none, with a mean price target of $20. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bearish. Over the past year the shares are up 76%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it none, with a mean price target of $20. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bearish. Over the past year the shares are up 76%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it none, with a mean price target of $20. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 5.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bearish. Over the past year the shares are up 76%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it none, with a mean price target of $20.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- NPK Announces New Executive Vice President, Commercial Growth & Operations Yahoo Finance · 14 Sep 2026
- NPK Announces Chief Financial Officer Retirement, Initiates Finance Leadership Succession Plan Yahoo Finance · 2 Sep 2026
- NPK International (NPKI) Positioned to Win as Utility Infrastructure Expands Insider Monkey · 7 Aug 2026
- NPK International (NPKI) Positioned to Win as Utility Infrastructure Expands Yahoo Finance · 7 Aug 2026
- NPK International Q2 Earnings Call Highlights MarketBeat · 31 Jul 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-02 | Minge John C | Dir | P - Purchase | 15,000 | $138,600 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $15.29 | -5.2% | · | $948 | -5.2% |
| 2 months | $15.03 | -3.6% | · | $964 | -3.6% |
| 3 months | $13.18 | +9.9% | · | $1,099 | +9.9% |
| 6 months | $13.10 | +10.6% | · | $1,106 | +10.6% |
| 1 year | $8.24 | +75.9% | · | $1,759 | +75.9% |
| 2 years | $8.38 | +72.9% | · | $1,729 | +72.9% |
| 3 years | $4.22 | +243.4% | · | $3,434 | +243.4% |
| 5 years | $3.77 | +284.4% | · | $3,844 | +284.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever NPKI does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.